Please ensure Javascript is enabled for purposes of website accessibility
Rigel Pharmaceuticals Stock Quote

Rigel Pharmaceuticals (NASDAQ: RIGL)

$1.34
(-4.3%)
-$0.06
Price as of March 22, 2023, 4:00 p.m. ET

You’re reading a free stock page from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Rigel Pharmaceuticals Returns vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
RIGL -56.66% -64.01% -18.49% -98%
S&P -10.27% +51.41% +8.65% +198%

Rigel Pharmaceuticals Company Info

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

News & Analysis

The Fool has written over 100 articles on Rigel Pharmaceuticals.

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
116%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 03/22/2023.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.